61 related articles for article (PubMed ID: 2530623)
1. Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences.
Litwin M; Michałkiewicz J; Gackowska L
Curr Hypertens Rep; 2013 Aug; 15(4):331-9. PubMed ID: 23737217
[TBL] [Abstract][Full Text] [Related]
2. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
Strauer BE; Bayer F; Brecht HM; Motz W
J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
[TBL] [Abstract][Full Text] [Related]
3. [Asymmetric septal hypertrophy in essential hypertension and sympathetic nervous system].
Kumagai E; Nomura G; Midorikawa K; Koga Y
Kokyu To Junkan; 1983 Jan; 31(1):63-6. PubMed ID: 6222450
[No Abstract] [Full Text] [Related]
4. Therapy of hypertensive hypertrophy.
Motz W; Strauer BE
Scand J Clin Lab Invest Suppl; 1989; 196():62-71. PubMed ID: 2530623
[No Abstract] [Full Text] [Related]
5. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
Frohlich ED
Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
[No Abstract] [Full Text] [Related]
6. [Possibilities of reverse development of left-ventricular hypertrophy in hypertension].
Bakhshaliev AB; Akhmetzianova EKh; Gadzhiev RF; Teboeva RV
Klin Med (Mosk); 1989 Mar; 67(3):10-7. PubMed ID: 2526273
[No Abstract] [Full Text] [Related]
7. Angiotensin blocking drugs and the heart beyond 2000.
Morgan TO; Delbridge LM
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S243-7. PubMed ID: 9892172
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic activity and myocardial anatomy and function in essential hypertension.
Muiesan G; Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1985 Dec; 3(4):S45-50. PubMed ID: 3007705
[TBL] [Abstract][Full Text] [Related]
9. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
Devereux RB; Pickering TG; Cody RJ; Laragh JH
J Clin Hypertens; 1987 Mar; 3(1):87-103. PubMed ID: 3033158
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
